FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4762711000001109: Crisantaspase 10,000unit powder for solution for injection vials 20 vial (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
21416501000001118 Crisantaspase 10,000unit powder for solution for injection vials 20 vial (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
21416601000001119 Crisantaspase 10,000unit powder for solution for injection vials 20 vial en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Crisantaspase 10,000unit powder for solution for injection vials 20 vial Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Crisantaspase 10,000unit powder for solution for injection vials 20 vial Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Crisantaspase 10,000unit powder for solution for injection vials 20 vial Has VMP Crisantaspase 10,000unit powder for solution for injection vials true Inferred relationship Existential restriction modifier
Crisantaspase 10,000unit powder for solution for injection vials 20 vial Is pack of Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) false Inferred relationship Existential restriction modifier
Crisantaspase 10,000unit powder for solution for injection vials 20 vial Has active ingredient Crisantaspase false Inferred relationship Existential restriction modifier
Crisantaspase 10,000unit powder for solution for injection vials 20 vial Has active ingredient Asparaginase false Inferred relationship Existential restriction modifier
Crisantaspase 10,000unit powder for solution for injection vials 20 vial Has active ingredient L-asparaginase false Inferred relationship Existential restriction modifier
Crisantaspase 10,000unit powder for solution for injection vials 20 vial Has VMP Crisantaspase 10,000unit powder for solution for injection vials false Inferred relationship Existential restriction modifier
Crisantaspase 10,000unit powder for solution for injection vials 20 vial VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Crisantaspase 10,000unit powder for solution for injection vials 20 vial VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Crisantaspase 10,000unit powder for solution for injection vials 20 vial Has manufactured dose form Powder for conventional release solution for injection false Inferred relationship Existential restriction modifier
Crisantaspase 10,000unit powder for solution for injection vials 20 vial Has VMP Product containing precisely asparaginase (as crisantaspase) 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) false Inferred relationship Existential restriction modifier
Crisantaspase 10,000unit powder for solution for injection vials 20 vial Has specific active ingredient Asparaginase false Inferred relationship Existential restriction modifier
Crisantaspase 10,000unit powder for solution for injection vials 20 vial Has dispensed dose form Powder for conventional release solution for injection true Inferred relationship Existential restriction modifier
Crisantaspase 10,000unit powder for solution for injection vials 20 vial Has specific active ingredient Crisantaspase true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Erwinase 10,000unit powder for solution for injection vials (Porton Biopharma Ltd) 20 vial Is a True Crisantaspase 10,000unit powder for solution for injection vials 20 vial Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start